Use the Back button in your browser to see the other results of your search or to select another record.
| Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial |
| Esposito K, Pontillo A, di Palo C, Giugliano G, Masella M, Marfella R, Giugliano D |
| JAMA 2003 Apr 9;289(14):1799-1804 |
| clinical trial |
| 8/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: Yes; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: Yes; Adequate follow-up: Yes; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
|
CONTEXT: Obesity is an independent risk factor for cardiovascular disease, which may be mediated by increased secretion of proinflammatory cytokines by adipose tissue. OBJECTIVE: To determine the effect of a program of changes in lifestyle designed to obtain a sustained reduction of body weight on markers of systemic vascular inflammation and insulin resistance. DESIGN AND SETTING: Randomized single-blind trial conducted from February 1999 to February 2002 at a university hospital in Italy. PATIENTS: One hundred twenty premenopausal obese women (body mass index >= 30) aged 20 to 46 years without diabetes, hypertension, or hyperlipidemia. INTERVENTIONS: The 60 women randomly assigned to the intervention group received detailed advice about how to achieve a reduction of weight of 10% or more through a low-energy Mediterranean-style diet and increased physical activity. The control group (n = 60) was given general information about healthy food choices and exercise. MAIN OUTCOME MEASURES: Lipid and glucose intake; blood pressure; homeostatic model assessment of insulin sensitivity; and circulating levels of interleukin 6 (IL-6), interleukin 18 (IL-18), c-reactive protein (CRP), and adiponectin. RESULTS: After 2 years, women in the intervention group consumed more foods rich in complex carbohydrates (9% corrected difference; p < 0.001), monounsaturated fat (2%; p = 0.009), and fiber (7 g/d; p < 0.001); had a lower ratio of omega-6 to omega-3 fatty acids (-5; p < 0.001); and had lower energy (-310 kcal/d; p < 0.001), saturated fat (-3.5%; p = 0.007), and cholesterol intake (-92 mg/d; p < 0.001) than controls. Body mass index decreased more in the intervention group than in controls (-4.2; p < 0.001), as did serum concentrations of IL-6 (-1.1 pg/mL; p = 0.009), IL-18 (-57 pg/mL; p = 0.02), and CRP (-1.6 mg/L; p = 0.008), while adiponectin levels increased significantly (2.2 microg/mL; p = 0.01). In multivariate analyses, changes in free fatty acids (p = 0.008), IL-6 (p = 0.02), and adiponectin (p = 0.007) levels were independently associated with changes in insulin sensitivity. CONCLUSION: In this study, a multidisciplinary program aimed to reduce body weight in obese women through lifestyle changes was associated with a reduction in markers of vascular inflammation and insulin resistance.
|